Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
Multiple Sclerosis: Changes in Microarchitecture of White Matter Tracts after Training with a Video Game Balance Board.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
Neurofilaments as biomarkers in multiple sclerosis.
Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects.
Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.
Heat shock protein 27 in multiple sclerosis relapses.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Haplotypes across the human caveolin 1 gene upstream purine complex significantly alter gene expression: Implication in neurodegenerative disorders.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641)
Diffusion tensor imaging of the corticospinal tract and walking performance in multiple sclerosis.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
Substance Name: MEDI 551
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Could Intrathymic Injection of Myelin Basic Protein Suppress Inflammatory Response After Co-culture of T Lymphocytes and BV-2 Microglia Cells?
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
[Neuromyelitis optica.]
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Minoderm
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »